Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
According to Novo Nordisk's latest financial reports the company's total assets are $43.25 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $46.57 B | 34.06% |
2022-12-31 | $34.74 B | 17.32% |
2021-12-31 | $29.61 B | 23.62% |
2020-12-31 | $23.95 B | 27.2% |
2019-12-31 | $18.83 B | 10.97% |
2018-12-31 | $16.97 B | 2.85% |
2017-12-31 | $16.50 B | 19.48% |
2016-12-31 | $13.81 B | 2.66% |
2015-12-31 | $13.45 B | 6.88% |
2014-12-31 | $12.58 B | -3.35% |
2013-12-31 | $13.02 B | 11.84% |
2012-12-31 | $11.64 B | 3.31% |
2011-12-31 | $11.27 B | 2.85% |
2010-12-31 | $10.95 B | 3.91% |
2009-12-31 | $10.54 B | 10.71% |
2008-12-31 | $9.52 B | 1.84% |
2007-12-31 | $9.35 B | 18.02% |
2006-12-31 | $7.92 B | 19.47% |
2005-12-31 | $6.63 B | -3.33% |
2004-12-31 | $6.86 B | 17.64% |
2003-12-31 | $5.83 B | 28.52% |
2002-12-31 | $4.53 B | 9.1% |
2001-12-31 | $4.16 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Pfizer PFE | $226.50 B | 423.61% | ๐บ๐ธ USA |
Eli Lilly LLY | $63.94 B | 47.82% | ๐บ๐ธ USA |
Sanofi SNY | $139.81 B | 223.22% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $99.03 B | 128.93% | ๐บ๐ธ USA |